Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 2:31 PM UTC
| NCT Number | NCT06961968 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Vanda Pharmaceuticals |
| Last Updated on CT.gov | January 12, 2026 (Jan 12, 2026) |
As of July 18, 2026: Clinical trial NCT06961968 is currently recruiting participants. This phase3 study for schizophrenia is actively seeking new participants at 22 locations across the United States. The study is sponsored by Vanda Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06961968 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06961968 was last updated Jan 12, 2026 (January 12, 2026). HelloStudys verifies this status automatically.